The purpose of this multi-center, prospective, observational registry is to gather information on the clinical outcomes and real-world use of commercially available bone graft substitutes manufactured by OssDsign® AB, in patients who require spine fusion.
Degenerative Disc Disease, Spinal Stenosis
The purpose of this multi-center, prospective, observational registry is to gather information on the clinical outcomes and real-world use of commercially available bone graft substitutes manufactured by OssDsign® AB, in patients who require spine fusion.
OssDsign® Spine Registry Study ("Propel")
-
Community Health Partners Neuroscience, Fresno, California, United States, 93720
San Diego Neurosurgery, San Diego, California, United States, 92024
Orthopedic Associates of Hartford, Hartford, Connecticut, United States, 06102
Yale Center for Clinical Investigation, Yale School of Medicine, New Haven, Connecticut, United States, 06519
Minimally Invasive Spine Center of South Florida, Miami, Florida, United States, 33133
Foundation for Orthopaedic Research and Education, Tampa, Florida, United States, 33607
Northeast Georgia Medical Center, Gainesville, Georgia, United States, 30501
Carle Foundation Hospital, NeuroScience Institute, Urbana, Illinois, United States, 61801
Orthopaedic Institute of Western Kentucky, Paducah, Kentucky, United States, 42001
OrthoBethesda Research Foundation, Bethesda, Maryland, United States, 20817
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
21 Years to
ALL
No
OssDsign,
Melanie Marshall, STUDY_DIRECTOR, OssDsign
2027-04-01